Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FVKR1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,185
Award facts
- Contract value 100% obligated
- $12,184.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,184.93 to AmerisourceBergen Drug Corp for AIMOVIG 140 MG/ML autoinjectors, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order issued under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to supply a broad range of pharmaceutical products and medical supplies supporting military healthcare systems worldwide. AIMOVIG (erenumab) is a monoclonal antibody medication used for migraine prevention, and this autoinjector formulation supports the medical needs of the Department of Defense and potentially other federal healthcare customers. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills such delivery orders across multiple therapeutic domains through its established DLA relationship.
Quick answers
Who was awarded contract SPE2DB25FVKR1?
SPE2DB25FVKR1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FVKR1 worth?
The government has obligated $12,185 on SPE2DB25FVKR1.
Is contract SPE2DB25FVKR1 an order under another contract?
Yes. SPE2DB25FVKR1 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVKR1 competed?
The extent of competition for SPE2DB25FVKR1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award